UnitedHealth Group Inc[2]
NEW YORK STOCK EXCHANGE, INC. · Health Care · mkt cap $391.69B
Jul 16, 2026 · Q2 FY2026 · Before open[1]
$430.04[3]
-0.3%
UnitedHealth Group Inc recently reported earnings; revenue status is inline and EPS status is beat versus available estimates.
| Metric | Actual | Estimate | Surprise | Verdict |
|---|---|---|---|---|
| Revenue | $112.03B[8] | $111.96B[1] | +0.1% | |
| EPS | $6.38[1] | $4.94[6] | +29.1% | |
| Guidance | unavailable | |||
Reaction session: Jul 16, 2026 · report-day session[5]
No evidence-backed AI interpretation is available for this report.
AI interpretation was not requested for this report.
| Quarter | Reported | Revenue | EPS | Gross margin | Op. margin | Net income |
|---|---|---|---|---|---|---|
| Q2 | Jul 16, 2026 | actual: $112.03B[8]est.: $111.96B[1]surp.: +0.1%[1+] | actual: $6.38[1]est.: $4.94[6]surp.: +29.1%[1+] | 32.7%[8] | 7.1%[8] | $5.48B[8] |
| Q1 |
| Apr 21, 2026 |
actual: $111.72B[8]est.: unavailablesurp.: unavailable |
actual: $7.23[6]est.: $6.60[6]surp.: +9.5%[6] |
| 22.7%[8] |
| 8.0%[8] |
| $6.28B[8] |
| Q4 | Jan 27, 2026 | actual: $113.22B[8]est.: unavailablesurp.: unavailable | actual: $2.11[6]est.: $2.11[6]surp.: 0.0%[6] | 16.3%[8] | 0.3%[8] | $10M[8] |
| Q3 | Oct 28, 2025 | actual: $113.16B[8]est.: unavailablesurp.: unavailable | actual: $2.92[6]est.: $2.81[6]surp.: +3.9%[6] | 18.2%[8] | 3.8%[8] | $2.35B[8] |
| Q2 | Jul 29, 2025 | actual: $111.62B[8]est.: unavailablesurp.: unavailable | actual: $4.08[6]est.: $4.45[6]surp.: -8.3%[6] | 17.9%[8] | 4.6%[8] | $3.41B[8] |
| Q1 | Apr 17, 2025 | actual: $109.58B[8]est.: unavailablesurp.: unavailable | actual: $7.20[6]est.: $7.29[6]surp.: -1.2%[6] | 21.7%[8] | 8.3%[8] | $6.29B[8] |
| Q4 | Jan 16, 2025 | actual: $100.81B[8]est.: unavailablesurp.: unavailable | actual: $6.81[6]est.: $6.74[6]surp.: +1.0%[6] | 21.1%[8] | 7.7%[8] | $5.54B[8] |
| Q3 | Oct 15, 2024 | actual: $100.82B[8]est.: unavailablesurp.: unavailable | actual: $7.15[6]est.: $7.03[6]surp.: +1.7%[6] | 22.8%[8] | 8.6%[8] | $6.06B[8] |
Sourced actuals only
vs. prior quarter +0.3%
| Field | Current | Prior quarter | Change |
|---|---|---|---|
| Revenue | $112.03B[8] | $111.72B[8+] | +0.3% |
| EPS | $6.38[1] | $7.23[6] | -11.8% |
| Gross margin | 32.7%[8] | 22.7%[8+] | +43.9% |
| Guidance | unavailable | — | unavailable |
| Management tone | neutral[4] | — | — |
| Period | Reported | Rev act / est | EPS act / est | 1d | 5d |
|---|---|---|---|---|---|
| 2026-06-30 | Jul 16, 2026 | unavailable / unavailable | $6.38[6] / $4.94[6] | unavailable | unavailable |
| 2026-03-31 | Apr 21, 2026 | unavailable / unavailable | $7.23[6] / $6.60[6] | unavailable | unavailable |
| 2025-12-31 | Jan 27, 2026 | unavailable / unavailable | $2.11[6] / $2.11[6] | unavailable | unavailable |
| 2025-09-30 | Oct 28, 2025 | unavailable / unavailable | $2.92[6] / $2.81[6] | unavailable | unavailable |
| 2025-06-30 | Jul 29, 2025 | unavailable / unavailable | $4.08[6] / $4.45[6] | unavailable | unavailable |
| 2025-03-31 | Apr 17, 2025 | unavailable / unavailable | $7.20[6] / $7.29[6] | unavailable | unavailable |
| 2024-12-31 | Jan 16, 2025 | unavailable / unavailable | $6.81[6] / $6.74[6] | unavailable | unavailable |
| 2024-09-30 | Oct 15, 2024 | unavailable / unavailable | $7.15[6] / $7.03[6] | unavailable | unavailable |
unavailable
Call takeaway
Management tone is neutral, guidance tone is more positive, and risk language is unavailable. Extracted 5 analyst questions and 4 adjacent management responses from the original transcript.[4]
...the year to end up. Then on commercial, can you talk about the magnitude of the cost trend pressure you're seeing here versus that 11% expectations and maybe update us on how we should think about commercial margins this year and the trajectory versus the previous assumption?
I know the goal had been to do that by 2028. Do you feel like you're going to do obviously better than that this year? Do you think you're on a sustainable track now to have that 13%-16% growth going forward?
...least in the first half of the year. Then just as we think about what you assumed in the bids that you finalized a month or so ago, was that closer to the first half experience for trend or something closer to what you saw in 2025 or expected to see, I guess, going into 2026?
...eline to be thinking about for 2027 if you kind of assume normal growth from here, or is there anything we should be thinking about, either whether it was prior period development or outperformance that an MA that gets rebid to next year? How should we be thinking about that?
How should I think about the investments that you're making and the benefits that you could see? Again, to your point, Wayne, is there anything that's one time in nature?
News unavailable.
8-K8-K[11]
filed Jul 16, 2026
QVeris · get_earnings_calendar · retrieved 2026-07-23 11:13 UTC
QVeris · get_company_profile · retrieved 2026-07-23 11:13 UTC
QVeris · get_stock_quote · retrieved 2026-07-23 11:13 UTC
QVeris · get_earnings_transcript · retrieved 2026-07-23 11:13 UTC
QVeris · get_historical_prices · retrieved 2026-07-23 11:13 UTC
QVeris · get_historical_earnings · retrieved 2026-07-23 11:13 UTC
QVeris · get_revenue_segments · retrieved 2026-07-23 11:13 UTC
QVeris · get_income_statement · retrieved 2026-07-23 11:13 UTC
QVeris · get_balance_sheet · retrieved 2026-07-23 11:13 UTC
QVeris · get_cash_flow · retrieved 2026-07-23 11:13 UTC
QVeris · get_sec_filings · retrieved 2026-07-23 11:13 UTC
Missing: news, revisions